Co-Diagnostics Inc

NASDAQ:CODX  
8.36
-0.07 (-0.83%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)239.27M
Current PE5.70
Forward PE 7.6
2yr Forward PE 15.48
See more stats
Estimates Current Quarter
Revenue$20.91 Million
Adjusted EPS$0.12
See more estimates
10-Day MA$8.89
50-Day MA$8.82
200-Day MA$9.61
See more pivots

Co-Diagnostics Inc Stock, NASDAQ:CODX

2401 South Foothill Drive, Suite D, Salt Lake City, Utah 84109
United States of America
Phone: +1.801.438.1036
Number of Employees: 37

Description

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight H. Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.